Literature DB >> 18579190

Xanthogranulomatous inflammation of urachus mimicking urachal carcinoma.

Tricia L C Kuo1, Christopher Cheng.   

Abstract

Urachal xanthogranuloma is rare. In this case, the patient presented with a lower abdominal mass and elevated inflammatory markers. The computed tomography findings of xanthogranulomatous urachitis resemble those of urachal carcinoma and, although rare, this entity should be included in the differential diagnosis of urachal masses.

Entities:  

Mesh:

Year:  2008        PMID: 18579190     DOI: 10.1016/j.urology.2008.02.045

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Thyroglossal Duct Cyst Associated with Xanthogranulomatous Inflammation.

Authors:  Orhun Cig Taskin; Hasan Gucer; Daniel Winer; Ozgur Mete
Journal:  Head Neck Pathol       Date:  2015-04-21

2.  Xanthogranulomatus inflammatory lesion mimicker of malignancy: A clinicopathological study from rural India.

Authors:  Mani Krishna; Seema Dayal
Journal:  North Clin Istanb       Date:  2021-10-06

Review 3.  Xanthogranulomatous inflammation involving latissimus dorsi donor site and implant breast reconstruction: case report and literature review.

Authors:  Tasadooq Hussain; Bilal Elahi; Ervine Long; Tapan Mahapatra; Penelope L McManus; Peter J Kneeshaw
Journal:  World J Surg Oncol       Date:  2012-08-20       Impact factor: 2.754

4.  Xanthogranulomatous prostatitis with prostato-rectal fistula: a case report and review of the literature.

Authors:  Liyong Xing; Zhifei Liu; Gang Deng; Huan Wang; Yanfeng Zhu; Peng Shi; Bingyue Huo; Yindong Li
Journal:  Res Rep Urol       Date:  2016-09-16

Review 5.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.